Manufacturers Life Insurance Company, The Next Cure, Inc. Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.6 - $10.28 $91,017 - $123,113	-11,976 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$9.81 - $13.88 $7,730 - $10,937	788 Added 7.04%	11,976 $120,000
Q4 2020 Feb 12, 2021	BUY	$9.47 - $12.43 $10,928 - $14,344	1,154 Added 11.5%	11,188 $122,000
Q2 2020 Aug 10, 2020	BUY	$21.19 - $40.2 $14,451 - $27,416	682 Added 7.29%	10,034 $223,000
Q1 2020 May 15, 2020	BUY	$32.32 - $58.37 $302,256 - $545,876	9,352 New	9,352 $347,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $22.2M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.